Cargando…

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies

Mostrar otras versiones (1)

The use of neutralizing antibodies is one of the most successful methods to interfere with receptor-ligand interactions in vivo. In particular blockade of soluble inflammatory mediators or their corresponding cellular receptors was proven an effective way to regulate inflammation and/or prevent its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ejrnaes, Mette, von Herrath, Matthias G., Christen, Urs
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2270772/ https://www.ncbi.nlm.nih.gov/pubmed/17162375 http://dx.doi.org/10.1080/17402520600800721

Ejemplares similares

Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Ejrnaes, Mette, et al.
Publicado: (2006)

Retracted: Cure of Chronic Viral Infection and Virus-Induced Type 1 Diabetes by Neutralizing Antibodies
por: Journal of Immunology Research,
Publicado: (2016)

Resolution of a chronic viral infection after interleukin-10 receptor blockade
por: Ejrnaes, Mette, et al.
Publicado: (2006)

Can We Learn From Viruses How to Prevent Type 1 Diabetes?: The Role of Viral Infections in the Pathogenesis of Type 1 Diabetes and the Development of Novel Combination Therapies
por: von Herrath, Matthias
Publicado: (2009)

Viral Trigger for Type 1 Diabetes: Pros and Cons
por: Filippi, Christophe M., et al.
Publicado: (2008)

Potential viral pathogenic mechanism in human type 1 diabetes
por: Schneider, Darius A., et al.
Publicado: (2014)

Blockade but Not Overexpression of the Junctional Adhesion Molecule C Influences Virus-Induced Type 1 Diabetes in Mice
por: Christen, Selina, et al.
Publicado: (2013)

Functional Redundancy of CXCR3/CXCL10 Signaling in the Recruitment of Diabetogenic Cytotoxic T Lymphocytes to Pancreatic Islets in a Virally Induced Autoimmune Diabetes Model
por: Coppieters, Ken T., et al.
Publicado: (2013)

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes
por: Coppieters, Ken, et al.
Publicado: (2018)

Antigen-Specific Immunotherapy for Type 1 Diabetes: Maximizing the Potential
por: Peakman, Mark, et al.
Publicado: (2010)

The Type 1 Diabetes Signature: Hardwired to Trigger Inflammation?
por: Coppieters, Ken T., et al.
Publicado: (2014)

Immunotherapy for the Prevention and Treatment of Type 1 Diabetes: Optimizing the path from bench to bedside
por: Bresson, Damien, et al.
Publicado: (2009)

Immunosuppressive Mechanisms During Viral Infectious Diseases
por: Sarikonda, Ghanashyam, et al.
Publicado: (2010)

Recent advances in understanding Type 1 Diabetes
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

A Deeper Look into Type 1 Diabetes – Imaging Immune Responses during Onset of Disease
por: Christoffersson, Gustaf, et al.
Publicado: (2016)

New Insights Into the Role of Autoreactive CD8 T Cells and Cytokines in Human Type 1 Diabetes
por: Bender, Christine, et al.
Publicado: (2021)

Current and future therapies for type 1 diabetes
por: von Scholten, Bernt Johan, et al.
Publicado: (2021)

Direct Infection of Dendritic Cells during Chronic Viral Infection Suppresses Antiviral T Cell Proliferation and Induces IL-10 Expression in CD4 T Cells
por: Baca Jones, Carmen, et al.
Publicado: (2014)

Non-antigenic and antigenic interventions in type 1 diabetes
por: Rydén, Anna KE, et al.
Publicado: (2013)

SIGNIFICANCE OF BIVALENCE OF ANTIBODY IN VIRAL NEUTRALIZATION
por: Rosenstein, Robert W., et al.
Publicado: (1971)

Antibody and complement-dependent viral neutralization
por: Cooper, Neil R., et al.
Publicado: (1979)

Preexisting Autoantibodies Predict Efficacy of Oral Insulin to Cure Autoimmune Diabetes in Combination With Anti-CD3
por: Mamchak, Alusha A., et al.
Publicado: (2012)

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection
por: Holdener, Martin, et al.
Publicado: (2008)

Virus-induced autoimmune disease
por: Herrath, Matthias G von, et al.
Publicado: (1996)

Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
por: Pham, Minh N., et al.
Publicado: (2016)

Response to Comment on Rodriguez-Calvo et al. Increase in Pancreatic Proinsulin and Preservation of β-Cell Mass in Autoantibody-Positive Donors Prior to Type 1 Diabetes Onset. Diabetes 2017;66:1334–1345
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2017)

Viral infection prevents diabetes by inducing regulatory T cells through NKT cell–plasmacytoid dendritic cell interplay
por: Diana, Julien, et al.
Publicado: (2011)

Viral neutralization by antibody-imposed physical disruption
por: Zheng, Qingbing, et al.
Publicado: (2019)

To prescreen or not to prescreen for broadly neutralizing antibody sensitivity in HIV cure-related trials
por: Patel, Hursch, et al.
Publicado: (2023)

T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
por: Juedes, Amy E., et al.
Publicado: (2004)

Trading off fiscal budget adherence and child protection
por: Cavalca, Petra Gram, et al.
Publicado: (2022)

Interference with pancreatic sympathetic signaling halts the onset of diabetes in mice
por: Christoffersson, Gustaf, et al.
Publicado: (2020)

TRANSITORY APPEARANCE OF TYPE 2 NEUTRALIZING ANTIBODY IN PATIENTS INFECTED WITH TYPE 1 POLIOMYELITIS VIRUS
por: Sabin, Albert B.
Publicado: (1952)

Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection
por: Gounder, Anshu P., et al.
Publicado: (2016)

Erratum. Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes. Diabetes 2014;63:3880–3890
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2016)

The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes
por: Bender, Christine, et al.
Publicado: (2020)

Complete mapping of viral escape from neutralizing antibodies
por: Doud, Michael B., et al.
Publicado: (2017)

A Recombinant Avian Leukosis Virus Subgroup J for Directly Monitoring Viral Infection and the Selection of Neutralizing Antibodies
por: Wang, Qi, et al.
Publicado: (2014)

Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes
por: Rodriguez-Calvo, Teresa, et al.
Publicado: (2014)

Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy
por: Goh, Yun Shan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h56vfocac882glng3r46q3063q